ONC Q2 2021 Earnings — BeOne Medicines Ltd. Revenue & Financial Results | Market Cap Arena

ONCBeOne Medicines Ltd.

$33B

Q2 2021 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$150M+128.5% YoY

Gross Profit

$114M75.8% margin

Operating Income

-$475M-316.6% margin

Net Income

-$480M-320.2% margin

EPS (Diluted)

$-5.20

QoQ Revenue Growth

-75.2%

Cash Flow

Operating Cash Flow

-$420M

Free Cash Flow

-$459M

Stock-Based Comp.

$65M

Balance Sheet

Total Assets

$5.5B

Total Liabilities

$1.9B

Stockholders' Equity

$3.6B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$150M	$66M	+128.5%
Gross Profit	$114M	$51M	+121.6%
Operating Income	-$475M	-$359M	-32.3%
Net Income	-$480M	-$335M	-43.3%